Status:
COMPLETED
Trial of a Novel Chitosan Hemostatic Sealant in the Management of Complicated Epistaxis
Lead Sponsor:
HemCon Medical Technologies, Inc
Conditions:
Epistaxis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Purpose: This study is a prospective clinical trial to investigate the efficacy of a chitosan-coated nasal packing (ChitoFlex® used in conjunction with the HemCon Nasal Plug) in the management of dif...
Detailed Description
Epistaxis is a common reason for emergency department visits and otolaryngology referral. Management methods of epistaxis include nasal packing, chemical or electric cauterization, and arterial ligati...
Eligibility Criteria
Inclusion
- Minimum age of 18 years.
- Epistaxis despite nasal packing or rebleeding after removal of the packing.
Exclusion
- Patient unable or unwilling to provide informed consent.
- Prior diagnosis of disease or medical condition affecting the ability of blood to clot (e.g., hemophilia.)
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00863356
Start Date
March 1 2009
End Date
June 1 2009
Last Update
November 28 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Union Memorial Hospital
Baltimore, Maryland, United States, 21218